Pine Bridge Investments, L.P. Avadel Pharmaceuticals PLC Transaction History

Pine Bridge Investments, L.P.

  • $13.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$8.48 - $16.48 $13,941 - $27,093
-1,644 Reduced 39.88%
2,478 $40,000
Q1 2023

May 12, 2023
SELL
$6.41 - $9.95 $20,428 - $31,710
-3,187 Reduced 43.6%
4,122 $37,000
Q2 2022

Aug 05, 2022
BUY
$1.07 - $6.95 $6,429 - $41,762
6,009 Added 462.23%
7,309 $18,000
Q1 2022

May 12, 2022
BUY
$5.46 - $8.29 $7,098 - $10,776
1,300 New
1,300 $9,000

Others Institutions Holding AVDL

# of Institutions
8
Shares Held
1.07M
Call Options Held
0
Put Options Held
0
View Full List

About AVADEL PHARMACEUTICALS PLC

AVDL Quotes by TradingView
  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $661M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email